Scientist Home FTR Hlth (SHFH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Oct 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SHFH SEC filings page.
Scientist Home FTR Hlth (SHFH) reported $204K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
The gross-profit engine exists, but overhead and reinvestment currently consume more than sales can fund.
Cash conversion is closely tracking the reported loss: operating loss was$232K versus operating cash flow of-$248K , indicating the loss is translating into cash use rather than being mainly non-cash. Free cash flow fell further to-$323K , showing that investing outlays deepen the cash drain beyond day-to-day operations.
The business has a cost-structure problem: gross margin was
The balance sheet is financed heavily by liabilities: liabilities equal
Financial Health Signals
We do not publish a peer-relative financial health score for Scientist Home FTR Hlth, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Scientist Home FTR Hlth scores 27.23, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $25.4M against total liabilities of $531K. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Scientist Home FTR Hlth reported a net loss of $232K while operations used $248K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Scientist Home FTR Hlth generated $212K in revenue in Q3 2026. This represents an increase of 435.3% from the same quarter a year earlier. Against the prior quarter it is up 155.8%.
Scientist Home FTR Hlth's EBITDA was $12K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Scientist Home FTR Hlth reported $8K in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Scientist Home FTR Hlth earned $0.00 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Scientist Home FTR Hlth held $14K in cash as of Q3 2026; no long-term debt figure is on record for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Scientist Home FTR Hlth's gross margin was 57.1% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 16.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 22.0 percentage points.
Scientist Home FTR Hlth's operating margin was 3.9% in Q3 2026, reflecting core business profitability. No change is given against Q3 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Scientist Home FTR Hlth's net profit margin was 3.9% in Q3 2026, showing the share of revenue converted to profit. No change is given against Q3 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
SHFH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $212K+435.3% | $83K+162.7% | $189K+321.1% | $88K | $40K-33.3% | $32K | $45K | N/A |
| Cost of Revenue | $91K+286.5% | $0-100.0% | $130K+416.0% | $55K | $24K-28.6% | $18K | $25K | N/A |
| Gross Profit | $121K+653.1% | $29K+115.0% | $59K+200.0% | $33K | $16K-39.1% | $14K | $20K | N/A |
| SG&A Expenses | $113K+76.5% | $127K+145.6% | $161K+1169.3% | $185K | $64K+161.3% | $52K | $13K | N/A |
| Operating Income | $8Kn/m | -$98Kn/m | -$102K-1559.4% | -$153K | -$48K-2581.6% | -$38K | $7K | N/A |
| EBITDA | $12Kn/m | -$94Kn/m | -$98K-1506.1% | -$151K | -$48K | -$38K | $7K | N/A |
| Income Tax | $0n/m | $0n/m | $0-100.0% | $0 | $0-100.0% | -$935 | $935 | N/A |
| Net Income | $8Kn/m | -$98Kn/m | -$102K-1784.6% | -$153K | -$48K-27440.0% | -$37K | $6K | N/A |
| EPS (Diluted) | $0.00n/m | $0.00n/m | $0.00n/m | -$0.01 | $0.00 | $0.00 | $0.00 | N/A |
| Diluted Shares (Avg) | 24M+0.2% | 24M+0.9% | 24M+1.0% | N/A | 24M | 24M | 23M | N/A |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense, EPS (Basic).
SHFH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $608K-15.9% | $530K+361.9% | $559K+2751.5% | $644K+2932.6% | $723K+1458.9% | $115K | $20K | $21K |
| Current Assets | $226K-30.6% | $125K+9.2% | $132K+573.2% | $192K+804.8% | $326K | $115K | $20K | $21K |
| Cash & Equivalents | $14K-95.0% | $9K-91.9% | $15K-5.0% | $69K+269.9% | $276K+1353.6% | $111K | $16K | $19K |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0 | $0 | $0 |
| Inventory | $129K+6387.3% | $34K+918.3% | $31K+806.8% | $34K+1194.5% | $2K | $3K | $3K | $3K |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0 | $0 | $0 |
| Total Liabilities | $686K+50.5% | $616K+875.2% | $547K+2697.1% | $531K+1847.2% | $456K+1124.4% | $63K | $20K | $27K |
| Current Liabilities | $424K+243.7% | $340K+438.6% | $252K+1188.5% | $214K+686.5% | $123K | $63K | $20K | $27K |
| Non-Current Liabilities | $262K-21.2% | $276Kn/m | $295Kn/m | $317Kn/m | $333K | $0 | $0 | $0 |
| Total Equity | -$78K-129.3% | -$86K-267.5% | $11K+42222.2% | $113Kn/m | $267K+2822.9% | $52K | $27 | -$6K |
| Retained Earnings | -$438Kn/m | -$447Kn/m | -$349Kn/m | -$247Kn/m | -$94K | -$46K | -$9K | -$15K |
Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt.
SHFH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
SHFH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.1%+16.5pp | 35.1%-7.8pp | 31.3%-12.6pp | 37.0% | 40.6%-3.9pp | 42.9% | 43.9% | N/A |
| Operating Margin | 3.9% | -118.1% | -54.1%-69.7pp | -173.4% | -120.8% | -120.9% | 15.6% | N/A |
| Net Margin | 3.9% | -118.1% | -54.1%-67.6pp | -173.4% | -120.8% | -117.9% | 13.5% | N/A |
| Return on Equity | N/A | N/A | -893.2%-23334.0pp | -134.7% | -17.9%-19.8pp | -72.2% | 22440.7% | N/A |
| Return on Assets | 1.4%+8.0pp | -18.5%+14.0pp | -18.3%-49.2pp | -23.7% | -6.6%-7.0pp | -32.4% | 30.9% | N/A |
| Current Ratio | 0.53-2.1x | 0.37-1.4x | 0.52-0.5x | 0.90+0.1x | 2.64 | 1.82 | 1.00 | 0.78 |
| Liabilities-to-Equity | N/A | N/A | 47.90-676.8x | 4.68 | 1.71-2.4x | 1.23 | 724.74 | N/A |
| Asset Turnover | 0.35+0.3x | 0.16-0.1x | 0.34-1.9x | 0.14 | 0.05-1.2x | 0.28 | 2.29 | N/A |
Not reported in any period shown, so not listed: Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: The current ratio is below 1.0 (0.90), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Scientist Home FTR Hlth SHFH | FY2025 | $204K | -$232K | N/A | $25.4M | — |
| Polomar Health Svcs Inc PMHS | FY2025 | $648K | N/A | N/A | $5.3M | — |
| Blum Holdings Inc. BLMH | FY2024 | $13.0M | $33.1M | N/A | $5.0M | — |
| Dalrada Technology Group DHTI | FY2025 | $20.3M | -$24.6M | N/A | $1.7M | — |
Where Scientist Home FTR Hlth Ranks
Frequently Asked Questions
Scientist Home FTR Hlth (SHFH) reported $204K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
No, Scientist Home FTR Hlth (SHFH) reported a net loss of $232K in fiscal year 2025.
Scientist Home FTR Hlth (SHFH) had EBITDA of -$230K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Scientist Home FTR Hlth (SHFH) had a gross margin of 40.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Scientist Home FTR Hlth (SHFH) has a return on equity of -204.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Scientist Home FTR Hlth (SHFH) recorded an outflow of $323K in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Scientist Home FTR Hlth (SHFH) recorded an outflow of $248K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Scientist Home FTR Hlth (SHFH) had $644K in total assets as of fiscal year 2025, including both current and long-term assets.
Scientist Home FTR Hlth (SHFH) invested $75K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Scientist Home FTR Hlth (SHFH) had a current ratio of 0.90 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Scientist Home FTR Hlth (SHFH) had a liabilities-to-equity ratio of 4.68 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
Scientist Home FTR Hlth (SHFH) had a return on assets of -36.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Scientist Home FTR Hlth (SHFH) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $25.4M as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Scientist Home FTR Hlth (SHFH) trades at 44.4x sales, its market capitalization divided by $572K revenue, trailing 12 months to September 30, 2026. The market capitalization is $25.4M as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, Scientist Home FTR Hlth (SHFH) held $69K in cash, cash equivalents and investments, and reported an operating cash outflow of $248K over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Scientist Home FTR Hlth (SHFH) has an Altman Z-Score of 27.23, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Scientist Home FTR Hlth (SHFH) reported a net loss of $232K while operations used $248K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.